A medical doctor just completed our webinar and said, verbatim:
"This is the best presentation I have ever seen and heard regarding body contouring and regenerative capabilities."
For qualified medical providers only · No obligation
Figures stated by James Finnegan, CEO & Founder, during the recorded webinar presentation.
Vice presidents at Blue Cross Blue Shield and Aetna have confirmed their internal strategy: reject claims two or three times, then pay a diminished 30–40% of the billable amount to providers who survive the "fatigue factor." It is a deliberate game designed to wear down practices.
Providers are sitting on $2 million in receivables and cannot keep their doors open. Reimbursements are not improving. They will not get better. They do not account for inflation.
"The only way to save your practice is cash-based procedures. The reimbursables are never improving."
This is not a generic sales pitch. It is a clinically grounded, financially detailed presentation that moves providers from skeptical to ready.
The 3D whipping rotation at 3,200–4,200 RPM. Why it extracts 40× more stem cells than bone marrow. Why it spares blood vessels, nerves, and fascia that every other device destroys.
Exact numbers: $4,400/month lease, $84,000 gross on 8 stem cell cases, $52,000 gross on 8 body contouring cases, $43,000–$45,000 net. One case covers the lease payment.
Adipose-derived stem cells vs. bone marrow vs. umbilical cord. Patient outcomes: fertility, Alzheimer's, Parkinson's, COPD, stage IV cancer. The concierge program at $100K/patient.
Clinical training, phone skills, consult scripts, 90-day managed marketing, Google AdWords, geofencing, and Facebook — all included. Zero providers have ever failed.
"This is the best presentation I have ever seen and heard regarding body contouring and regenerative capabilities."
"This was really pretty impressive and much more different than the other companies that have approached me. The results are very promising."
— Dr. Hague, verbatim during the webinar
"I have had so many people stop by my office — this is the most impressive. I am excited to discuss this with my hopefully future partner."
— Dr. Hague, verbatim during the webinar

These are the exact figures presented in the webinar — not projections, not estimates. Real revenue models from active providers.
A $4,400/month lease generating $43,000–$45,000/month net. That is a 10× ROI — and 33% of FunSculpting providers go on to purchase a second or third machine.
Across 550+ systems placed nationwide, not one provider has ever failed. Investors are now co-signing leases because the risk is that low.
No planned upgrades — ever. If any upgrade is released, it is provided free of charge. No $60,000/year upgrade traps like competing devices.
The only body contouring device in the world with a textbook written designating it the gold standard in both body contouring and adipose stem cell extraction.
Whether you do 100 cases a month or zero cases, FunSculpting does not make any more money. It is designed so you keep all the revenue.
All repairs and upgrades covered for two years. After that, pay per incident — James advises against the annual service contract because calls are nearly nonexistent.
Burned by equipment before? An investor co-signs the lease, splits the monthly payment, and takes 20% of revenues. You keep 80% and share the risk.
Providers across specialties are adding $30,000–$90,000/month in new cash revenue with zero system failures across 550+ deployments.
"This is the best presentation I have ever seen and heard regarding body contouring and regenerative capabilities."
"I was billing insurance for 30 years. The first month I ran 6 FunSculpting cases I netted more than I had in any single month of my career. I wish I had found this 10 years ago."
"My med spa had CoolSculpting, Emsculpt, and three lasers. I was doing $22,000 a month and working constantly. After adding FunSculpting I dropped two of those devices and now net $51,000 on fewer days."
"The investor partnership structure was the only reason I said yes. I had been burned by a $180,000 device that sat in the corner. This time my investor took the lease risk and I kept 80% of every case. Zero downside."
"My patients are 40–65, mostly women, many of them post-partum or post-menopausal. FunSculpting works on every body type and every skin tone. I have not had a single result I was unhappy with in 18 months."
"I looked at the 550-system track record and the zero-failure rate and thought — this is either the most extraordinary device in the industry or the most extraordinary marketing. After 12 months I can tell you it's the device."
Still have questions? Watch the full 68-minute webinar — James addresses every objection in detail.
Plastic surgeons and dermatologists want general anesthesia and surgical settings. FunSculpting is local anesthesia only — an in-office, aseptic dermatological procedure. The providers who thrive are those who say: "Let them do the nip and tucks. I'm focusing on localized treatments and stem cells."
Submit your information and a FunSculpting consultant will send you the full replay link and schedule a strategy call.